Premium
Increasing Antibiotic Resistance of Streptococcus Species in New York City
Author(s) -
Lin Karen,
Tierno Philip M.,
Komisar Arnold
Publication year - 2004
Publication title -
the laryngoscope
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.181
H-Index - 148
eISSN - 1531-4995
pISSN - 0023-852X
DOI - 10.1097/00005537-200407000-00003
Subject(s) - clindamycin , erythromycin , penicillin , streptococcus pyogenes , streptococcus pneumoniae , microbiology and biotechnology , antibiotics , antibiotic resistance , antimicrobial , medicine , population , biology , bacteria , staphylococcus aureus , environmental health , genetics
Objective: Streptococcus species are common pathogens in head and neck infections and are leading causes of morbidity and mortality. Emerging penicillin‐resistant streptococcal pathogens have shifted empirical antibiotic therapy in favor of valuable alternatives, including erythromycin and clindamycin. This study was undertaken to determine the magnitude of antimicrobial resistance to these antibiotics. Study Design: Retrospective review. Methods: A retrospective study of two streptococcal species isolates, Streptococcus pyogenes (163 specimens) and Streptococcus pneumoniae (164 specimens), collected between January 1, 2001 and January 1, 2002 at two academic institutions. The antibiotic susceptibility patterns were analyzed for penicillin, erythromycin, and clindamycin according to the National Committee for Clinical Laboratory Standards. Results: Fourteen percent to 34% of S. pyogenes isolates were erythromycin‐resistant, and 0% to 28% were clindamycin‐resistant. None of the S. pyogenes isolates were resistant to penicillin. Of the S. pneumoniae isolates, 33% to 50% were resistant to erythromycin, and 18% to 33% were resistant to clindamycin. The penicillin resistance levels for S. pneumoniae were 0% to 45%. Conclusions: Our antimicrobial resistance levels for S. pyogenes and S. pneumoniae significantly exceeded national and worldwide levels of erythromycin and clindamycin resistance. With a diverse population of over 8 million residents and high physician supply, our model is a microcosm for the study of antimicrobial use and susceptibility patterns and of clinical failure.